Companies · Listed company · 🇮🇳

Aster DM Quality Care Limited

ASTERDM · NSE · ₹692 a share (close of 05 Oct 2026)

Available company data, source links and archived checks for Aster DM Quality Care Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.

Revenue rose 21.6%; Net profit was ₹29.28 crore.

Quarter ended 2026-06-30 · consolidated · Company filing

Recorded quarterly figures

Quarter	Revenue / income	YoY	Profit	YoY	Net margin	Source
Jun 2026	Revenue: ₹1,311 cr	+21.6%	Net profit: ₹29 cr	-68.7%	2.2%	Company filing source
Mar 2026	Revenue: ₹1,182 cr	+18.2%	Net profit: ₹154 cr	+79.5%	13.0%	Company filing source
Dec 2025	Revenue: ₹1,186 cr	—	Net profit: ₹59 cr	—	4.9%	Company filing source
Sep 2025	Revenue: ₹1,197 cr	—	Net profit: ₹121 cr	—	10.1%	Company filing source
Jun 2025	Revenue: ₹1,078 cr	+7.6%	Net profit: ₹94 cr	-98.2%	8.7%	Company filing source
Mar 2025	Revenue: ₹1,000 cr	—	Net profit: ₹86 cr	—	8.6%	Company filing source

YoY means change from the same quarter a year earlier. — means no comparable figure is available. Older entries with incomplete source details have not been revalidated under the current checks.

Recently checked facts

ASTERDM: consolidated net profit changed by -68.7% in the quarter ending 30 June 2026, compared with the quarter ending 2025-06-30.

✓ verified by recomputing archived check · 2026-09-20 exchange filing →

ASTERDM: consolidated net profit for the quarter ending 30 June 2026 was ₹29.28 crore.

✓ verified by recomputing archived check · 2026-09-20 exchange filing →

ASTERDM: consolidated revenue changed by 21.6% in the quarter ending 30 June 2026, compared with the quarter ending 2025-06-30.

✓ verified by recomputing archived check · 2026-09-20 exchange filing →

ASTERDM: consolidated revenue for the quarter ending 30 June 2026 was ₹1,310.68 crore.

✓ verified by recomputing archived check · 2026-09-20 exchange filing →

All capacity, utilization, investment and timing figures are management-stated for the proposed project, and completion by May 2028 is a forward-looking target rather than a confirmed result.

✓ verified by reading the document archived check · 2026-09-20 exchange filing →

Who holds it — from the filings

Bcp Asia Ii Topco Iv Pte.Ltd. 29.7%Union Investments Private Limited 21.4%Centella Mauritius Holdings Limited 9.9%Hdfc Small Cap Fund 5.2%Rimco (Mauritius) Limited 4.1%register as filed 2026-07-13

Filing timeline — what the company told the exchange

Shareholders meeting. Aster DM Quality Care Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026. F… 30 Sep 2026 · document
Aster DM Quality Care Limited has informed the Exchange about Retirement of Ms. Purana Housdurgam Vijayadeepti (DIN: 08125456) as Non-Executive Independent Dire… 28 Sep 2026 · document
Aster DM Quality Care Limited has informed the Exchange regarding Appointment of Mrs Neela Bhattacherjee as Non- Executive Independent Director of the company w… 28 Sep 2026 · document
Aster DM Quality Care Limited has informed the Exchange regarding Change in Director(s) of the company.… 28 Sep 2026 · document
Shareholders meeting. Aster DM Quality Care Limited has informed the Exchange regarding summary proceedings of 18th Annual General Meeting held on September 28,… 28 Sep 2026 · document
Aster DM Quality Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015… 26 Sep 2026 · document
Shareholders meeting. Aster DM Quality Care Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the… 26 Sep 2026 · document
General Updates. Aster DM Quality Care Limited has informed the Exchange about issue of an Addendum to the Notice of 18th Annual General Meeting of the Company.… 19 Sep 2026 · document

Follow this company without reading every document yourself.

Keep its available filings, dated fact checks and disclosure alerts together. Your saved country sets your market and its research schedule.

Start free — first week on us →

India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment advice · cancel any time

Company data and archived claim checks are shown with available sources. Check the source and date before relying on a figure. This is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI. Terms, disclosures and grievances